Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug-Receptor Bonds01:25

Drug-Receptor Bonds

Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Design and optimization of potent, selective, and peripherally acting JNK3 inhibitors for chronic kidney disease.

European journal of medicinal chemistry·2026
Same author

c-Jun N-Terminal Kinase 3 as a Pathogenic Driver of Renal Fibrosis: Imidazo[2,1-<i>b</i>]thiazole-Based JNK3 Inhibitors Restore Podocyte Function in TGF-β-Mediated Glomerulosclerosis.

Journal of medicinal chemistry·2026
Same author

Advances in JNK inhibitor development: therapeutic prospects in neurodegenerative diseases and fibrosis.

Archives of pharmacal research·2025
Same author

Targeting JNK3 for Alzheimer's disease: Design and synthesis of novel inhibitors with aryl group diversity utilizing wide pocket.

European journal of medicinal chemistry·2025
Same author

Gaining Insights into Key Structural Hotspots within the Allosteric Binding Pockets of Protein Kinases.

International journal of molecular sciences·2024
Same author

Targeting the CSF-1/CSF-1R Axis: Exploring the Potential of CSF1R Inhibitors in Neurodegenerative Diseases.

Journal of medicinal chemistry·2024

Related Experiment Video

Updated: May 28, 2026

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

A python-based docking program utilizing a receptor bound ligand shape: PythDock.

Jae Yoon Chung1, Seung Joo Cho, Jung-Mi Hah

  • 1Department of Pharmacy, College of Pharmacy, Hanyang University, Ansan 426-791, Korea.

Archives of Pharmacal Research
|October 7, 2011
PubMed
Summary
This summary is machine-generated.

PythDock, a novel Python-based docking program, accurately predicts ligand-receptor interactions. It outperforms AutoDock and DOCK, offering a valuable tool for structure-based drug design and understanding molecular binding.

More Related Videos

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

Related Experiment Videos

Last Updated: May 28, 2026

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

Area of Science:

  • Computational chemistry
  • Molecular modeling
  • Drug discovery

Background:

  • Molecular docking is crucial for identifying drug candidates.
  • Existing docking programs have limitations in accuracy and computational efficiency.
  • Developing novel docking tools is essential for advancing structure-based drug design.

Purpose of the Study:

  • To introduce PythDock, a new heuristic docking program.
  • To evaluate PythDock's performance against established docking software.
  • To assess the accuracy of PythDock in predicting protein-ligand binding poses.

Main Methods:

  • PythDock utilizes Python, a simple scoring function (electrostatic, dispersion/repulsion), and particle swarm optimization.
  • A grid potential map is generated based on bound ligand shape for focused searching.
  • Performance was compared with AutoDock 4.2 and DOCK 6.2 using 14 protein-ligand complexes with varying ligand flexibility.

Main Results:

  • PythDock demonstrated higher accuracy in predicting ligand poses compared to AutoDock 4.2 and DOCK 6.2.
  • The average root mean squared deviation (RMSD) values indicated superior performance of PythDock.
  • Despite a simpler scoring function, PythDock achieved better results, highlighting the effectiveness of its search algorithm.

Conclusions:

  • PythDock is a promising and accurate tool for molecular docking.
  • Its performance suggests significant potential for applications in structure-based drug design.
  • PythDock can aid in the study of ligand-receptor interactions and accelerate drug discovery efforts.